CONMED CORP (CNMD) Stock Fundamental Analysis
USA - NYSE:CNMD - US2074101013 - Common Stock
42.04 USD
-1.23 (-2.84%)
42.04 USD
0 (0%)
CNMD gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 188 industry peers in the Health Care Equipment & Supplies industry. While CNMD has a great profitability rating, there are some minor concerns on its financial health. A decent growth rate in combination with a cheap valuation! Better keep an eye on CNMD. CNMD also has an excellent dividend rating. This makes CNMD very considerable for value and dividend investing!
1. Profitability
1.1 Basic Checks
In the past year CNMD was profitable.
In the past year CNMD had a positive cash flow from operations.
CNMD had positive earnings in 4 of the past 5 years.
In the past 5 years CNMD always reported a positive cash flow from operatings.
1.2 Ratios
With an excellent Return On Assets value of 4.73%, CNMD belongs to the best of the industry, outperforming 80.32% of the companies in the same industry.
With an excellent Return On Equity value of 10.97%, CNMD belongs to the best of the industry, outperforming 86.17% of the companies in the same industry.
With an excellent Return On Invested Capital value of 7.55%, CNMD belongs to the best of the industry, outperforming 82.45% of the companies in the same industry.
CNMD had an Average Return On Invested Capital over the past 3 years of 5.35%. This is below the industry average of 8.98%.
The 3 year average ROIC (5.35%) for CNMD is below the current ROIC(7.55%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.73% | ||
| ROE | 10.97% | ||
| ROIC | 7.55% |
ROA(3y)1.67%
ROA(5y)1.82%
ROE(3y)3.52%
ROE(5y)3.97%
ROIC(3y)5.35%
ROIC(5y)4.98%
1.3 Margins
Looking at the Profit Margin, with a value of 8.30%, CNMD belongs to the top of the industry, outperforming 80.32% of the companies in the same industry.
In the last couple of years the Profit Margin of CNMD has grown nicely.
The Operating Margin of CNMD (14.36%) is better than 82.98% of its industry peers.
CNMD's Operating Margin has improved in the last couple of years.
CNMD has a Gross Margin (56.05%) which is comparable to the rest of the industry.
CNMD's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 14.36% | ||
| PM (TTM) | 8.3% | ||
| GM | 56.05% |
OM growth 3Y13.62%
OM growth 5Y9.51%
PM growth 3Y17.76%
PM growth 5Y27.53%
GM growth 3Y-0.07%
GM growth 5Y0.25%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so CNMD is still creating some value.
CNMD has about the same amout of shares outstanding than it did 1 year ago.
CNMD has more shares outstanding than it did 5 years ago.
CNMD has a better debt/assets ratio than last year.
2.2 Solvency
CNMD has an Altman-Z score of 1.96. This is not the best score and indicates that CNMD is in the grey zone with still only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 1.96, CNMD is in the better half of the industry, outperforming 61.17% of the companies in the same industry.
The Debt to FCF ratio of CNMD is 5.91, which is a neutral value as it means it would take CNMD, 5.91 years of fcf income to pay off all of its debts.
CNMD's Debt to FCF ratio of 5.91 is fine compared to the rest of the industry. CNMD outperforms 77.13% of its industry peers.
CNMD has a Debt/Equity ratio of 0.88. This is a neutral value indicating CNMD is somewhat dependend on debt financing.
CNMD has a worse Debt to Equity ratio (0.88) than 73.94% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.88 | ||
| Debt/FCF | 5.91 | ||
| Altman-Z | 1.96 |
ROIC/WACC1.2
WACC6.28%
2.3 Liquidity
A Current Ratio of 2.23 indicates that CNMD has no problem at all paying its short term obligations.
CNMD's Current ratio of 2.23 is in line compared to the rest of the industry. CNMD outperforms 40.96% of its industry peers.
A Quick Ratio of 1.00 indicates that CNMD should not have too much problems paying its short term obligations.
The Quick ratio of CNMD (1.00) is worse than 77.13% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.23 | ||
| Quick Ratio | 1 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an nice 16.49% over the past year.
The Earnings Per Share has been growing by 9.44% on average over the past years. This is quite good.
Looking at the last year, CNMD shows a small growth in Revenue. The Revenue has grown by 5.00% in the last year.
CNMD shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 6.47% yearly.
EPS 1Y (TTM)16.49%
EPS 3Y9.03%
EPS 5Y9.44%
EPS Q2Q%2.86%
Revenue 1Y (TTM)5%
Revenue growth 3Y8.95%
Revenue growth 5Y6.47%
Sales Q2Q%6.7%
3.2 Future
The Earnings Per Share is expected to grow by 9.42% on average over the next years. This is quite good.
Based on estimates for the next years, CNMD will show a small growth in Revenue. The Revenue will grow by 5.42% on average per year.
EPS Next Y9.58%
EPS Next 2Y8.14%
EPS Next 3Y9.42%
EPS Next 5YN/A
Revenue Next Year5.05%
Revenue Next 2Y5.25%
Revenue Next 3Y5.42%
Revenue Next 5YN/A
3.3 Evolution
The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 9.30, which indicates a very decent valuation of CNMD.
93.62% of the companies in the same industry are more expensive than CNMD, based on the Price/Earnings ratio.
The average S&P500 Price/Earnings ratio is at 25.89. CNMD is valued rather cheaply when compared to this.
Based on the Price/Forward Earnings ratio of 8.64, the valuation of CNMD can be described as reasonable.
Compared to the rest of the industry, the Price/Forward Earnings ratio of CNMD indicates a rather cheap valuation: CNMD is cheaper than 94.68% of the companies listed in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 34.59. CNMD is valued rather cheaply when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 9.3 | ||
| Fwd PE | 8.64 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, CNMD is valued cheaply inside the industry as 93.09% of the companies are valued more expensively.
CNMD's Price/Free Cash Flow ratio is rather cheap when compared to the industry. CNMD is cheaper than 96.28% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 8.73 | ||
| EV/EBITDA | 8.15 |
4.3 Compensation for Growth
CNMD's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The excellent profitability rating of CNMD may justify a higher PE ratio.
PEG (NY)0.97
PEG (5Y)0.99
EPS Next 2Y8.14%
EPS Next 3Y9.42%
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 1.85%, CNMD has a reasonable but not impressive dividend return.
The stock price of CNMD dropped by -20.86% in the last 3 months. With lower prices the dividend yield is higher, but it may be a sign investors do not trust the long term dividend.
CNMD's Dividend Yield is rather good when compared to the industry average which is at 1.69. CNMD pays more dividend than 96.28% of the companies in the same industry.
Compared to the average S&P500 Dividend Yield of 2.44, CNMD is paying slightly less dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.85% |
5.2 History
The dividend of CNMD has a limited annual growth rate of 0.16%.
CNMD has paid a dividend for at least 10 years, which is a reliable track record.
CNMD has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)0.16%
Div Incr Years0
Div Non Decr Years12
5.3 Sustainability
22.72% of the earnings are spent on dividend by CNMD. This is a low number and sustainable payout ratio.
CNMD's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP22.72%
EPS Next 2Y8.14%
EPS Next 3Y9.42%
42.04
-1.23 (-2.84%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners114.95%
Inst Owner Change1.64%
Ins Owners0.27%
Ins Owner Change2.67%
Market Cap1.30B
Revenue(TTM)1.31B
Net Income(TTM)110.04M
Analysts73.33
Price Target62.99 (49.83%)
Short Float %6.82%
Short Ratio5.91
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.85% |
Yearly Dividend0.81
Dividend Growth(5Y)0.16%
DP22.72%
Div Incr Years0
Div Non Decr Years12
Ex-Date
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)7.57%
Min EPS beat(2)0.37%
Max EPS beat(2)14.78%
EPS beat(4)4
Avg EPS beat(4)7%
Min EPS beat(4)0.37%
Max EPS beat(4)14.78%
EPS beat(8)7
Avg EPS beat(8)4.79%
EPS beat(12)10
Avg EPS beat(12)-0.43%
EPS beat(16)13
Avg EPS beat(16)0.77%
Revenue beat(2)1
Avg Revenue beat(2)-0.12%
Min Revenue beat(2)-0.75%
Max Revenue beat(2)0.51%
Revenue beat(4)1
Avg Revenue beat(4)-0.8%
Min Revenue beat(4)-2.4%
Max Revenue beat(4)0.51%
Revenue beat(8)1
Avg Revenue beat(8)-1.21%
Revenue beat(12)3
Avg Revenue beat(12)-1.83%
Revenue beat(16)4
Avg Revenue beat(16)-1.82%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)1.69%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.43%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 9.3 | ||
| Fwd PE | 8.64 | ||
| P/S | 0.98 | ||
| P/FCF | 8.73 | ||
| P/OCF | 7.84 | ||
| P/B | 1.3 | ||
| P/tB | N/A | ||
| EV/EBITDA | 8.15 |
EPS(TTM)4.52
EY10.75%
EPS(NY)4.87
Fwd EY11.57%
FCF(TTM)4.82
FCFY11.46%
OCF(TTM)5.36
OCFY12.76%
SpS42.85
BVpS32.37
TBVpS-13.15
PEG (NY)0.97
PEG (5Y)0.99
Graham Number57.38
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.73% | ||
| ROE | 10.97% | ||
| ROCE | 9.37% | ||
| ROIC | 7.55% | ||
| ROICexc | 7.68% | ||
| ROICexgc | 26.02% | ||
| OM | 14.36% | ||
| PM (TTM) | 8.3% | ||
| GM | 56.05% | ||
| FCFM | 11.24% |
ROA(3y)1.67%
ROA(5y)1.82%
ROE(3y)3.52%
ROE(5y)3.97%
ROIC(3y)5.35%
ROIC(5y)4.98%
ROICexc(3y)5.42%
ROICexc(5y)5.05%
ROICexgc(3y)20.07%
ROICexgc(5y)18.29%
ROCE(3y)6.64%
ROCE(5y)6.18%
ROICexgc growth 3Y14.56%
ROICexgc growth 5Y8.78%
ROICexc growth 3Y13.61%
ROICexc growth 5Y10.93%
OM growth 3Y13.62%
OM growth 5Y9.51%
PM growth 3Y17.76%
PM growth 5Y27.53%
GM growth 3Y-0.07%
GM growth 5Y0.25%
F-Score7
Asset Turnover0.57
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.88 | ||
| Debt/FCF | 5.91 | ||
| Debt/EBITDA | 3.34 | ||
| Cap/Depr | 23.06% | ||
| Cap/Sales | 1.27% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 62.96% | ||
| Profit Quality | 135.51% | ||
| Current Ratio | 2.23 | ||
| Quick Ratio | 1 | ||
| Altman-Z | 1.96 |
F-Score7
WACC6.28%
ROIC/WACC1.2
Cap/Depr(3y)25.27%
Cap/Depr(5y)22.96%
Cap/Sales(3y)1.54%
Cap/Sales(5y)1.52%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)16.49%
EPS 3Y9.03%
EPS 5Y9.44%
EPS Q2Q%2.86%
EPS Next Y9.58%
EPS Next 2Y8.14%
EPS Next 3Y9.42%
EPS Next 5YN/A
Revenue 1Y (TTM)5%
Revenue growth 3Y8.95%
Revenue growth 5Y6.47%
Sales Q2Q%6.7%
Revenue Next Year5.05%
Revenue Next 2Y5.25%
Revenue Next 3Y5.42%
Revenue Next 5YN/A
EBIT growth 1Y11.85%
EBIT growth 3Y23.79%
EBIT growth 5Y16.6%
EBIT Next Year45.54%
EBIT Next 3Y17.93%
EBIT Next 5YN/A
FCF growth 1Y837.86%
FCF growth 3Y16.7%
FCF growth 5Y15.48%
OCF growth 1Y347.44%
OCF growth 3Y14.31%
OCF growth 5Y11.92%
CONMED CORP / CNMD FAQ
What is the ChartMill fundamental rating of CONMED CORP (CNMD) stock?
ChartMill assigns a fundamental rating of 6 / 10 to CNMD.
What is the valuation status of CONMED CORP (CNMD) stock?
ChartMill assigns a valuation rating of 8 / 10 to CONMED CORP (CNMD). This can be considered as Undervalued.
How profitable is CONMED CORP (CNMD) stock?
CONMED CORP (CNMD) has a profitability rating of 8 / 10.
What is the valuation of CONMED CORP based on its PE and PB ratios?
The Price/Earnings (PE) ratio for CONMED CORP (CNMD) is 9.3 and the Price/Book (PB) ratio is 1.3.
How financially healthy is CONMED CORP?
The financial health rating of CONMED CORP (CNMD) is 5 / 10.